This review aims to (1) explore the biological role of mucins and their applicability to glioma, (2) evaluate means of measurement and levels of mucin detection, and (3) provide an exploratory framework for the study and advancement of mucins as precision biomarkers in the glioma setting. The gene discussed is MUC5AC; the disease is central nervous system cancer.